USPTO serial 79308367
SEGOVA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 22, 2022
- Examiner
- SPARACINO, MARK V
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SEGOVA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Alexander Lazouski
Alexander Lazouski LAZOUSKI IP LLCSUITE 1, 14726 BOWFIN TER.LAKEWOOD RANCH, FL 34202UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Alcohols for pharmaceutical use; alcohol for topical application; analgesics; anesthetics; antibacterial products for washing hands, namely, antibacterial handwash; antibacterial cleaners; antibacterial preparations, namely, antibacterial cleaners; antiseptic preparations; balms for veterinary use; biological preparations for medical use for the treatment of reproductive health diseases, disorders and conditions; biological reagents for medical use; biotechnological preparations for medical use for the treatment of reproductive health diseases, disorders and conditions; multi-purpose medicated antibiotic creams; lint for medical use; disinfectants; diagnostic substances, preparations and agents for medical use; medical dressings; contrast products used with medical equipment, namely, contrast media for in-vivo imaging for medical use; blood for medical use; medicinal and pharmaceutical preparations used for the treatment of reproductive health diseases, disorders and conditions; drugs for medical use, namely, pharmaceutical preparations for the treatment of reproductive health diseases, disorders and conditions; stem cells for medical use; surgical implants grown from stem cells; surgical implants made of living tissue; biological tissue cultures for medical use; hygiene preparations for medical use, namely, disinfectants; dietetic beverages and foods for medical use; food supplements for human beings; reagents for use in medical genetic testing; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical substances and preparations used in gynecology | ACTIVE | — |
| 010 | Surgical and medical apparatus and instruments for use in general surgery; genetic analysis apparatus for medical use; apparatus for the regeneration of stem cells for medical use; clinical diagnosis apparatus, namely, diagnostic apparatus for the detection of reproductive health diseases, disorders and conditions; blood testing apparatus; dropper bottles for medical use, namely, dropper bottles for administering medication, sold empty; vaginal dilators; vaginal syringes; gynecological apparatus and instruments; digital thermometers for medical use; uterine dilators; endoscopic apparatus for medical use; protective gloves for medical use; needles for medical use; injection instruments without needles; suture materials; blood collection bags for medical use; lasers for surgical use; medical instruments for cutting tissue; enema apparatus for medical use; medical apparatus for introducing pharmaceutical preparations into the human body; knives for medical use; protection devices against X-rays, for medical use, namely, patient x-ray radiation shields; pessaries; scalpels; apparatus for non-invasive surgery; ultrasound apparatus for medical use; ultrasonic diagnostic apparatus for medical use; diagnostic imaging apparatus for medical use; hygiene masks for medical use; syringes for medical use; multi-injection needle syringes | ACTIVE | — |
| 044 | Medical services; medical and health care services; obstetric and gynecology services; ambulatory health care services; hospital services; genetic consultation, namely, genetic counseling; genetic testing for medical use; dermatology services; DNA screening for medical use; medical services relating to the removal, treatment and transformation of stem cells; medical services relating to the collection, treatment and processing of human blood, umbilical cord blood, human cells, stem cells and bone marrow; health and beauty care for human beings; medical equipment rental; preparation of reports in connection with medical matters; provision of information in the field of administration of medication; medical consultancy and information services relating to medical products; medical consultant and information services relating to pharmaceutical products; medical assistance; medical care services; medical and health care clinic services; medical consultation services; medical screening; medical counselling; medical testing for diagnostic or treatment purposes; conducting of medical examinations; plastic surgery; preparation of prescriptions by pharmacists; medical information; laboratory analysis services relating to the treatment of persons, namely, medical analysis services for diagnostic and treatment purposes provided by medical laboratories; services provided by a doctor, namely, medical services; medical diagnosis of genetic diseases; medical clinic services; telemedicine services; medical rehabilitation clinic services; medical analysis services relating to the treatment of persons provided by a medical laboratory; pharmacy advice regarding preparation of prescriptions in pharmacies; physiotherapy | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Vincula Biotech Group d.o.o.
- Other trademarks owned by Vincula Biotech Group d.o.o.
- Other trademarks owned by Forever Young d.o.o.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 044
- Similar marks named SEGOVA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 4, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 22, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 2, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 2, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 22, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 22, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 4, 2022 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Dec 7, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 7, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 6, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 17, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 17, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 17, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 2, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 21, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 21, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 21, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Oct 19, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 19, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 19, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 21, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 20, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 20, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 24, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 2, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 1, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 29, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 28, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 22, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 16, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 12, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 8, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |